FTC sues to block Amgen acquisition of Horizon Therapeutics

Hits: 6

Amgen wants to buy Horizon Therapeutics to bolster is drug portfolio as it faces patent expirations. The FTC fears the deal could entrench monopoly positions. Read More Go To Source